Stock Events

Stock Events

Karyopharm Therapeutics (25K0.F) Q1 2026 Earnings

12FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-4.81

-3.77

-2.72

-1.68

Details

Expected EPS

-1.6802657264399998

Actual EPS

-4.8109034

Surprise EPS

-3.13

Surprise Percent

+186.32%

Description

Karyopharm Therapeutics (25K0.F) has reported earnings of -4.8109034 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.